An allosteric pocket for inhibition of bacterial Enzyme I identified by NMR-based fragment screening

被引:9
|
作者
Nguyen, Trang T. [1 ]
Venditti, Vincenzo [1 ,2 ]
机构
[1] Iowa State Univ, Dept Chem, Hach Hall,2438 Pammel Dr, Ames, IA 50011 USA
[2] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA
来源
关键词
Mixed inhibition; Competitive inhibition; Antimicrobial compounds; Principal component analysis; Bacterial phosphotransferase system; TIM barrel enzyme; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; VIRULENCE GENES; PROTEIN; PHOSPHOENOLPYRUVATE; SYSTEM; PHOSPHORYLATION; LIGAND; PARAMETERIZATION;
D O I
10.1016/j.yjsbx.2020.100034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Enzyme I (EI), which is the key enzyme to activate the bacterial phosphotransferase system, plays an important role in the regulation of several metabolic pathways and controls the biology of bacterial cells at multiple levels. The conservation and ubiquity of EI among different types of bacteria makes the enzyme a potential target for antimicrobial research. Here, we use NMR-based fragment screening to identify novel inhibitors of EI. We identify three molecular fragments that allosterically inhibit the phosphoryl transfer reaction catalyzed by EI by interacting with the enzyme at a surface pocket located more than 10 angstrom away from the substrate binding site. Interestingly, although the three molecules share the same binding pocket, we observe that two of the discovered EI ligands act as competitive inhibitors while the third ligand acts as a mixed inhibitor. Characterization of the EI-inhibitor complexes by NMR and Molecular Dynamics simulations reveals key interactions that perturb the fold of the active site and provides structural foundation for the different inhibitory activity of the identified molecular fragments. In particular, we show that contacts between the inhibitor and the side-chain of V292 are crucial to destabilize binding of the substrate to EI. In contrast, mixed inhibition is caused by additional contacts between the inhibitor and alpha-helix 2 that perturb the active site structure and turnover in an allosteric manner. We expect our results to provide the basis for the development of second generation allosteric inhibitors of increased potency and to suggest novel molecular strategies to combat drug-resistant infections.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Using NMR-Based Fragment Screening to Probe the Druggability of Regulator of G Protein Signaling 17
    Hayes, Michael Patrick
    Fowler, C. Andrew
    Yu, Liping
    Roman, David L.
    FASEB JOURNAL, 2016, 30
  • [22] Cracking the molecular weight barrier: Fragment screening of an aminotransferase using an NMR-based functional assay
    Mendoza, Renaldo
    Petros, Andrew M.
    Liu, Yaya
    Thimmapaya, Rama
    Surowy, Carol S.
    Leise, Walter F.
    Pereda-Lopez, Ana
    Panchal, Sanjay C.
    Sun, Chaohong
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5248 - 5250
  • [23] Potent Inhibitors of Mycobacterium tuberculosis Growth Identified by Using in-Cell NMR-based Screening
    DeMott, Christopher M.
    Girardin, Roxie
    Cobbert, Jacqueline
    Reverdatto, Sergey
    Burz, David S.
    McDonough, Kathleen
    Shekhtman, Alexander
    ACS CHEMICAL BIOLOGY, 2018, 13 (03) : 733 - 741
  • [24] Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A2A Receptor Targeting the Sodium Ion Pocket
    Lu, Yan
    Liu, Hongyue
    Yang, Dehua
    Zhong, Li
    Xin, Ye
    Zhao, Suwen
    Wang, Ming-Wei
    Zhou, Qingtong
    Shui, Wenqing
    ACS CHEMICAL BIOLOGY, 2021, 16 (06) : 991 - 1002
  • [25] NMR-based screening in drug discovery and design
    Hajduk, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2762 - U2762
  • [26] NMR-Based Screening of Membrane Protein Ligands
    Yanamala, Naveena
    Dutta, Arpana
    Beck, Barbara
    van Fleet, Bart
    Hay, Kelly
    Yazbak, Ahmad
    Ishima, Rieko
    Doemling, Alexander
    Klein-Seetharaman, Judith
    CHEMICAL BIOLOGY & DRUG DESIGN, 2010, 75 (03) : 237 - 256
  • [27] Protein NMR-based screening in drug discovery
    Zartler, E. R.
    Shapiro, M. J.
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (31) : 3963 - 3972
  • [28] Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors
    Jahnke, W
    Blommers, MJJ
    Fernández, C
    Zwingelstein, C
    Amstutz, R
    CHEMBIOCHEM, 2005, 6 (09) : 1607 - +
  • [29] Analysis of bacterial biofilms using NMR-based metabolomics
    Zhang, Bo
    Powers, Robert
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (10) : 1273 - 1306
  • [30] NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds
    Yu, Jun-lan
    Chen, Tian-tian
    Zhou, Chen
    Lian, Fu-lin
    Tang, Xu-long
    Wen, Yi
    Shen, Jing-kang
    Xu, Ye-chun
    Xiong, Bing
    Zhang, Nai-xia
    ACTA PHARMACOLOGICA SINICA, 2016, 37 (07) : 984 - 993